Gout

Latest News

Gout Increases Incident Stroke Risk by the Same Magnitude as Diabetes

Gout Increases Incident Stroke Risk by the Same Magnitude as Diabetes

A recent study assessed whether gout is a cardiovascular risk equivalent for stroke and myocardial infarction, similar to diabetes.

FDA Alert: Febuxostat May Increase Risk of Heart-Related Adverse Events, Death

FDA Alert: Febuxostat May Increase Risk of Heart-Related Adverse Events, Death

Gout medication febuxostat (Uloric) was associated with an increased risk of heart-related death and death from all causes.

Online Consultation System Benefits Rheumatic Disease Management

Online Consultation System Benefits Rheumatic Disease Management

The SSDM series of applications is cost-effective for patients of rheumatologists.

Lesinurad for Gout: Efficacious but not Safe

Lesinurad for Gout: Efficacious but not Safe

Despite rapidly lowering serum uric acid levels, lesinurad cannot be recommended alone at 400 mg per day, due to substantial adverse events.

FDA Approves Duzallo for Hyperuricemia Associated With Uncontrolled Gout

FDA Approves Duzallo for Hyperuricemia Associated With Uncontrolled Gout

The US FDA has approved a new fixed-dose and dual-mechanism treatment option for uncontrolled gout.

High Levels of Serum Uric Acid May Increase Risk for Dementia in the Elderly

High Levels of Serum Uric Acid May Increase Risk for Dementia in the Elderly

Older adults with high serum uric acid levels might be at increased risk of developing vascular or mixed dementia.

Lesinurad, Febuxostat Combination Treatment Improves Tophaceous Gout Symptoms

Lesinurad, Febuxostat Combination Treatment Improves Tophaceous Gout Symptoms

Patients with tophaceous gout undergoing combination therapy with lesinurad and febuxostat showed a greater degree of symptom resolution than with febuxostat monotherapy.

Recall: Gout Pills Found in Platelet Inhibitor Sample Bottle

Recall: Gout Pills Found in Platelet Inhibitor Sample Bottle

Accidental patient dosing with Zurampic can potentially cause adverse renal effects such as acute renal failure; this is more common if Zurampic is given alone without a xanthine oxidase inhibitor.

Analysis of Factors Improving Rx Adherence in Patients with Gout

Analysis of Factors Improving Rx Adherence in Patients with Gout

Belief about medicines, presence of comorbidity, and being married positively influence adherence to medication.

DASH Diet May Help Lower Occurrence of Gout

DASH Diet May Help Lower Occurrence of Gout

Following the diet may be a good option for patients who prefer to avoid medication.

Sign Up for Free e-newsletters